← SynDRA
OZANIMOD
SynDRA canonical compound SYN0038444 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Approval status | Approved · Rx |
|---|
| Primary target(s) | S1PR1 |
|---|
| Mechanism of action | sphingosine 1-phosphate receptor agonist |
|---|
All known targets
- S1PR1
- S1PR5
- S1PR2
- S1PR3
- S1PR4
Mechanisms of action (all sources)
- S1PR1 MODULATOR
- Sphingosine 1-phosphate receptor Edg-1 modulator
- S1PR5 MODULATOR
- Sphingosine 1-phosphate receptor 5 modulator
- sphingosine 1-phosphate receptor agonist
- S1PR1 AGONIST
- S1PR5 AGONIST
Drug classes
- Immunologic Factors
- Immunosuppressive Agents
- Sphingosine 1 Phosphate Receptor Modulators
- Sphingosine 1-Phosphate Receptor Modulators
- Sphingosine 1-phosphate Receptor Modulator
ATC classes
- L04A · IMMUNOSUPPRESSANTS
Cross-references
Synonyms
- RPC1063
- RPC-1063
- ozanimod hydrochloride
- Ozanimod (RPC1063)
- UNII-Z80293URPV
- Z80293URPV
- (S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
- Ozanimod [USAN:INN]
- Ozanimod (USAN/INN)
- SCHEMBL2195490
- GTPL8709
- CHEMBL3707247
- 5-[3-[(1S)-1-(2-hydroxyethylamino)-2,3-dihydro-1H-inden-4-yl]-1,2,4-oxadiazol-5-yl]-2-propan-2-yloxybenzonitrile
- EX-A1316
- s7952
- ZINC116109867
- AKOS026674086
- DB12612
- CS-5070
- HY-12288
- AC-29883
- Benzonitrile, 5-(3-((1
- RPC 1063
- Ozanimodum
- RefChem:58151
- L04AA38
- DTXCID201510666
- MFCD28386168
- Ozanimod [INN]
- Ozanimod (Standard)
- OZANIMOD [USAN]
- Ozanimod; RPC1063
- OZANIMOD [MI]
- OZANIMOD [WHO-DD]
- orb1300342
- SCHEMBL29560683
- SCHEMBL29691988
- CHEBI:234516
Reported adverse events
- Headache
- Hypersensitivity
- Hypertension
- Infection
- Orthostatic hypotension
- Urinary tract infection
- Bradyarrhythmia
- Arthralgia
- Back pain
- Nausea
- Pyrexia
- Ulcer
Look up OZANIMOD in the interactive SynDRA portal →